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Results. Radiotherapy was well tolerated with complete remission in 83.4% of them. Acute toxicities were low grade nausea and
vomiting, without late toxicity. The median follow-up are 48 months, actually 7 patients are disease-free, 2 with cutaneous EICH.
The other 5 patients are dead, 3 of them by relapse.
Conclusion. TBI has been a central part of allogenic transplantation for LMA and LLA, with chemotherapy is used to destroy
disordered cells and to immunosuppress prior to transplantation for decrease the EICH. The TBI has a relative advantage in its
using is that the dose delivery throughout the body is controllable in each organ. In our review the results are similar than the
others series published with overall-survival (range 45–65%), the transplant related mortality (ranged 20–22%) and the probability
of relapse (range 20–40%).
http://dx.doi.org/10.1016/j.rpor.2013.03.379
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Introduction. Fractionated stereotactic radiotherapy (FSRT) is an advantage strategy in pediatric brain tumors treatment.
Purpose. This study attempts to analyses our experience in terms of local control overall survival and acute and late toxicities
with FSRT in pediatrics patients with brain tumors.
Methods. Between February 2008 and December 2012, nine children with brain tumors were treated with FSRT: three pilocytic
astrocytomas, two glioma stem, pineal endodermal tumor, anaplastic ganglioglioma, PNET pineal and Ewing’s sarcoma intracra-
nial recurrence. 3-T MRI was performed previously to treatment administration. Subsequently a CT with Brainlab thermoplastic
mask was carried out, using a Frameless system that provides accurate daily set up. CT image fusion MRI and an iPlan planning
systemwereperformed for dosimetry. All patients received 50–54Gywith 3Dconformal radiotherapyor IntensityModulatedRadi-
ation Therapy “sliding windows” (diffuse glioma recurrence stem and recurrence Ewing’s sarcoma) in a Novalis Linac (Brainlab®),
adapted to stereotactic treatments. Daily veriﬁcation of the treatment was performed with IGRT Exactrac® system, using a 6D
robotic couch, infrared camera andorthogonal X-rays. Toxicitywas assessed according toNCICTCvs 4.0. Local-failure free survival
and overall survival (LFFS) was obtained using the Kaplan–Meier method.
Results. Median follow up from the primary diagnosis was 54 months (5–131). Local recurrence was observed in 4 patients (the 5
year actuarial LFFS rate was 58.9%) and actuarial overall survival was 60.6% at 5 year. The treatment in all cases was well tolerated
and no grade >3 acute and late neurological toxicities due to the radiotherapy treatment were reported.
Conclusion. The FRST with IGRT is a feasible, safety and accurate treatment for pediatric brain tumors, although the small sample
size evaluated. Beneﬁts and toxicities of this approach should be assessed in prospective clinical trials in order to deﬁne the role
of FSRT in pediatric brain tumors.
http://dx.doi.org/10.1016/j.rpor.2013.03.380
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Introduction. First described by Billroth in 1856, ACC is a rare pathologic ﬁnding that comprises 10% of salivary gland neoplasms.
The most common type is squamous cell carcinoma. The management is challenging because of its insidious growth pattern
(perineural involvement) and tendency for distant metastasis. Surgery represents the main treatment. No deﬁnitive policy exists
regarding postoperative radiotherapy (RT) or elective node treatment. Research is lacking on newer radiation techniques. RT is
recommended to help local control if skull base, neck metastasis, perineural invasion or relapse. We present the case of a patient
with ACC of the external ear treated by intensity-modulated radiotherapy (IMRT).
Materials and method (case report). A 36 year-old female visited the ENT clinic with a three years history of otalgia, and hearing loss.
Physical examination, MR and PET-CT scan revealed an expansive lesion in the upper-posterior wall of the EAC. Biopsy: ACC. The
patient underwent a radical surgery, including bone samples and right neck dissection. Pathology: AAC with perineural, mastoid
and EAC wall invasion. No pathologic lymph nodes. Postoperative IMRT-IGRT was started at our institution in July 2012. MRI and
PET CT scan were reviewed for target delineation. The target volume was deﬁned as the surgical bed and suspicious areas with
a 0.3 cm margin. Technique: step and shoot IMRT (8 beams, with 38 segments). Prescribed dose: 66Gy at 2Gy per fraction
Results. The patient was seen after RT with controversial results as PET-CT showed local activity. Re-assessment with surgery
and MRI scan revealed no pathologic ﬁndings. With 6 months follow-up time, there is no evidence of disease. No severe toxicity
has been reported.
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Conclusions. IMRT seems to be an ideal modality for tumours of the EAC/middle ear. However, further research is needed to
determine volumes, dose or suitability of the elective node irradiation.
http://dx.doi.org/10.1016/j.rpor.2013.03.381
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Introduction. The incidence of secondary cancers in paediatric patients is especially high, since children have a longer life
expectancy. There is evidence that Intensity Modulated Radiation Therapy (IMRT) increases the risk for developing secondary
malignancies, compared to conventional therapies (3D-CRT). Seven paediatric neuroblatoma patients were treated at our center
with Volumetric Modulated Arc Therapy (VMAT).
Objectives. This study evaluates dose distribution of VMAT to normal tissues proximal and distal to the PTV as compared to
3D-CRT and IMRT.
Method. A 3D-CRT and an IMRT ﬁve-ﬁeld plan were designed and compared to a VMAT plan. TPS Philips Pinnacle V9.0. Treatment
unit: Elekta Synergy linac. Two regions were deﬁned for estimation of dose distribution to normal tissues. The ﬁrst region covered
the entire body except for the PTV and the lower extremities. The second region was a 5-cm ring around the PTV. We calculated
the maximum dose (Dmax), mean dose (Dmean), and integral dose (ID) for both regions in the three plans. We also performed a
comparison of the number of monitor units (MU). Statistical analysis was performed using Friedman and Wilkinson tests with
the Bonferroni correction (p<0.017).
Results. Similar dose pattern values were obtained for both regions in the three plans. Dmax values were similar in all three
techniques. Dmean values were similar between IMRT and VMAT (p=0.043) and both lower than in 3D-CRT (p=0.018). There were
signiﬁcant differences in MUs with the lowest mean value found in the VMAT plan. ID was higher for 3DCRT (p=0.018), and
similar between IMRT and VMAT (p=0.043).
Conclusions. Dose distribution was similar in VMAT and IMRT. The Dmean dose was lower and MUs were higher in VMAT, compared
to 3D-CRT. The incidence of secondary cancers may be lower in VMAT-treated patients, as compared to IMRT-treated patients.
Nevertheless, these conclusions should be considered with caution, given the small sample size.
http://dx.doi.org/10.1016/j.rpor.2013.03.382
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Purpose. To evaluate retrospectively the efﬁcacy of low-dose radiotherapy in degenerative painful osteoarthritis.
Patients and methods. From January 2006 to December 2012, 63 degenerative osteoarthritis of the knee (40 p, 81.6%), shoulder (4
p, 8.2%), hip (2 p, 4.1%) or plantar heel spur (3 p, 6.1%) from 49 distinctive patients underwent low-dose radiotherapy for pain
control. Analyzed series included 40 women and 9 men, with a median age of 85 years (range 42–91 years). Painful status was
measured by visual analogue scale (VAS), with a median pre-treatment value of VAS=8 (range 4–10). A median radiotherapy dose
of 5Gy (range 3–6Gy) was delivered in 10 daily fractions of 50 cGy. In those patients with a post-treatment VAS of or above 6, a
second course of identical radiotherapy was proposed.
Results. Initial response was evaluated 4 weeks after the end of treatment, with a median VAS=4 (range 1–10). Twenty-ﬁve
painful sites underwent a second course of radiotherapy with identical dose and median time interval between two treatments
of 8 weeks (range 4–63 weeks). With a median follow-up of 11 months (range 1–97 months), median VAS at last visit was of 3
(range 0–8). Two patients (4.1%) reported VAS=0, 29 p (59.2%) VAS=1–3, 16 p (32.7%) VAS=4–7 and 2 p (4.1%) VAS=8–10. Daily
requirements of analgesics were removed or substantially reduced in 44p (89.8%). Subjective patient perception of response to
irradiation evaluated at time of last visit regarding to pre-treatment status was considered as “better” by 91.8% of patients. No
patients presented acute or late complications attributable to radiation treatment.
Conclusions. Low-dose radiotherapy is an effective alternative for treatment of degenerative painful osteoarthritis.
http://dx.doi.org/10.1016/j.rpor.2013.03.383
